Adjuvants: no longer a ‘dirty little secret’, but essential key players in vaccines of the future
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvants: no longer a ‘dirty little secret’, but essential key players in vaccines of the future
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 10, Issue 1, Pages 1-5
Publisher
Informa UK Limited
Online
2010-12-16
DOI
10.1586/erv.10.140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a metabolically active, non-replicating sporozoite vaccine to preventPlasmodium falciparummalaria
- (2010) Stephen L. Hoffman et al. Human vaccines & immunotherapeutics
- PATH Malaria Vaccine Initiative (MVI): Perspectives on the status of malaria vaccine development
- (2010) Ashley J. Birkett Human vaccines & immunotherapeutics
- Plasmodium vivax Ookinete Surface Protein Pvs25 Linked to Cholera Toxin B Subunit Induces Potent Transmission-Blocking Immunity by Intranasal as Well as Subcutaneous Immunization
- (2010) T. Miyata et al. INFECTION AND IMMUNITY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Glycoconjugate vaccines and immune interference: A review
- (2010) Ron Dagan et al. VACCINE
- Immunology of TLR-independent vaccine adjuvants
- (2009) Ennio De Gregorio et al. CURRENT OPINION IN IMMUNOLOGY
- Malaria Ookinete Surface Protein-Based Vaccination via the Intranasal Route Completely Blocks Parasite Transmission in both Passive and Active Vaccination Regimens in a Rodent Model of Malaria Infection
- (2009) T. Arakawa et al. INFECTION AND IMMUNITY
- Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
- (2009) Vasee S Moorthy et al. MALARIA JOURNAL
- Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
- (2009) John N. Waitumbi et al. PLoS One
- Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-γ/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection
- (2009) James F. Cummings et al. VACCINE
- Nanotechnology in vaccine delivery
- (2008) Laura J. Peek et al. ADVANCED DRUG DELIVERY REVIEWS
- Current Status of Vaccines for Schistosomiasis
- (2008) D. P. McManus et al. CLINICAL MICROBIOLOGY REVIEWS
- Alum adjuvanticity: Unraveling a century old mystery
- (2008) Ennio De Gregorio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Exploiting viral properties for the rational design of modern vaccines
- (2008) Gunther Spohn et al. Expert Review of Vaccines
- Malaria vaccines and their potential role in the elimination of malaria
- (2008) Geoffrey A Targett et al. MALARIA JOURNAL
- Molecular and cellular signatures of human vaccine adjuvants
- (2008) F. Mosca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Effects of radiation on the safety and protective efficacy of an attenuated Plasmodium yoelii sporozoite malaria vaccine
- (2008) Rana Chattopadhyay et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search